Influences of CYP2D6*10 polymorphisms on the pharmacokinetics of iloperidone and its metabolites in Chinese patients with schizophrenia: a population pharmacokinetic analysis

被引：0
|
作者：
Qi Pei
Lu Huang
Jie Huang
Jing-kai Gu
Yun Kuang
Xiao-cong Zuo
Jun-jie Ding
Hong-yi Tan
Cheng-xian Guo
Shi-kun Liu
Guo-ping Yang
机构：
[1] Third Xiangya Hospital,Center of Clinical Pharmacology and Pharmacy Department
[2] Central South University,undefined
[3] Drug Metabolism Research Center of Jilin University,undefined
[4] Children's Hospital of Fudan University,undefined
来源：
Acta Pharmacologica Sinica | 2016年 / 37卷
关键词：
schizophrenia; iloperidone; gene polymorphisms; 10; population pharmacokinetics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1499 / 1508
页数：9
相关论文
共 50 条
  • [31] Influence of CYP2D6 polymorphisms on symptomatology and sideeffects of patients with schizophrenia in Malaysia
    Zahari, Zalina
    Salleh, Mohd Razali
    Teh, Lay Kek
    Ismail, Rusli
    MALAYSIAN JOURNAL OF MEDICAL SCIENCES, 2009, 16 (03): : 13 - 21
  • [32] Polymorphisms of CYP2D6 in the Czech population.
    Slanar, Ondrej
    Buzkova, Helena
    Pechandova, Kristina
    Matouskova, Olga
    Perlik, Frantisek
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 232 - 232
  • [33] Effects of paroxetine on the pharmacokinetics of atomoxetine and its metabolites in different CYP2D6 genotypes
    Eui Hyun Jung
    Yun Jeong Lee
    Dong-Hyun Kim
    Pureum Kang
    Chang Woo Lim
    Chang-Keun Cho
    Choon-Gon Jang
    Seok-Yong Lee
    Jung-Woo Bae
    Archives of Pharmacal Research, 2020, 43 : 1356 - 1363
  • [34] Effects of paroxetine on the pharmacokinetics of atomoxetine and its metabolites in different CYP2D6 genotypes
    Jung, Eui Hyun
    Lee, Yun Jeong
    Kim, Dong-Hyun
    Kang, Pureum
    Lim, Chang Woo
    Cho, Chang-Keun
    Jang, Choon-Gon
    Lee, Seok-Yong
    Bae, Jung-Woo
    ARCHIVES OF PHARMACAL RESEARCH, 2020, 43 (12) : 1356 - 1363
  • [35] Effects of CYP2D6 genetic polymorphisms on the pharmacokinetics of tramadol and its active metabolite
    Lim, Hye-Jin
    Kim, B. S. Dong-Hyun
    Kim, Young-Hoon
    Kim, Se-Hyung
    Byeon, Ji-Yeong
    Lee, Seok-Yong
    PHARMACOTHERAPY, 2015, 35 (11): : E315 - E315
  • [36] A population pharmacokinetic evaluation of the influence of CYP2D6 genotype on risperidone metabolism in patients with acute episode of schizophrenia
    Locatelli, Igor
    Kastelic, Matej
    Koprivsek, Jure
    Kores-Plesnicar, Blanka
    Mrhar, Ales
    Dolzan, Vita
    Grabnar, Iztok
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 41 (02) : 289 - 298
  • [37] Atomoxetine pharmacokinetics in healthy Chinese subjects and effect of the CYP2D6*10 allele
    Cui, Yi M.
    Teng, Choo H.
    Pan, Alan X.
    Yuen, Eunice
    Yeo, Kwee P.
    Zhou, Ying
    Zhao, Xia
    Long, Amanda J.
    Bangs, Mark E.
    Wise, Stephen D.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 64 (04) : 445 - 449
  • [38] CYP2D6 polymorphisms and endoxifen concentration in Chinese patients with breast cancer
    Xue, Cong
    Yang, Wei
    Hu, Anqi
    He, Caiyun
    Liao, Hai
    Chen, Meiting
    An, Xin
    Wang, Shusen
    Yuan, Zhongyu
    Xu, Fei
    Tang, Jun
    Li, Haifeng
    Li, Su
    Shao, Jianyong
    Shi, Yanxia
    BMC CANCER, 2025, 25 (01)
  • [39] Pharmacokinetics of paroxetine and genotype of CYP2D6 polymorphisms in the Japanese patients with dose escalation
    Okazaki, N
    Yamauchi, A
    Nagai, H
    Nishimura, R
    Kataoka, Y
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2005, 97 : 278P - 278P
  • [40] Pharmacokinetics of nortriptyline and its 10-hydroxy metabolite in Chinese subjects of different CYP2D6 genotypes
    Yue, QY
    Zhong, ZH
    Tybring, G
    Dalén, P
    Dahl, ML
    Bertilsson, L
    Sjöqvist, F
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 64 (04) : 384 - 390
12345